CORAL LABORATORIES LTD. SHARE PRICE [LIVE]

BSE: INE683E01017   NSE: CORALAB   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
N/A
Change:
BSE
255.25
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in CORAL LABORATORIES LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

CORALAB News

Frequently Asked Questions

What is the Share price of CORAL LABORATORIES LTD. (CORALAB)?

CORAL LABORATORIES LTD. (CORALAB) share price as of May 27, 2022, on BSE is Rs 255.25 (BSE).

Can I buy CORAL LABORATORIES LTD. (CORALAB) shares?

Yes, You can buy CORAL LABORATORIES LTD. (CORALAB) shares by opening a Demat account with Angel One.

How do I buy CORAL LABORATORIES LTD. (CORALAB) from Angel One?

CORAL LABORATORIES LTD. (CORALAB) share can be brought through the following modes:
  1. Direct investment: You can buy CORAL LABORATORIES LTD. (CORALAB) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to CORAL LABORATORIES LTD. (CORALAB) shares.

In which sector do CORAL LABORATORIES LTD. (CORALAB) belong?

CORAL LABORATORIES LTD. (CORALAB) belongs to Pharma.

About CORALAB

Today's live share price for CORAL LABORATORIES LTD. is NSE: N/A, BSE: ₹ 255.25 with a current market capitalization of .

Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. The Coral group is also diversifying into housing construction and financial services for which a new company, Coral India Finance and Housing, will be incorporated. During the year 1999-2000, the company has received ISO-9002 Certification.

Read more